4Tuuminen T,Varjo S,Ingman H,et al.Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae mmunoglobulin G and A antibodies in a healthy Finnish population as analysed by quantitative enzyme immunoassays[J].Clin Diagn Lab Immunol,2000,7(5):734-738.
5Isogai E, Isogai H, Hirose K, et al. In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli 0157 infection[J]. Curt Microbiol, 2001,42(4): 248 ~ 251.
6Pierre V, Patrice F. Comparison of levofloxacin,alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus[J] . Antimicrobial Agents and Chemotherapy, 2002, 46 (5): 1503 - 1509.
7Ndrea G, Oscar C, Roberto G, et al. Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin- like peptides alone or combined with levofloxacin in rat models of septic shock[J] . Antimicrobial Agents and Chemotherapy, 2003,(suppl) : 292 - 296.
8Jones R N, Rubino C M. Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: Report from the antimicrobial resistance rate epidemiology study[J]. Antimicrobial Agents and Chemotherapy, 2003, 47 (1) : 292 - 296.
9Simon G, Moyosoluwa O, Glenn W K. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus [J].Journal of Antimicrobial Chemotherapy, 2003, 51:13 - 17.
10Susan L P, Mariela K W G. Bactericidal activity and postantibiotic effect of lvofloxacin against anaerobes[J] .Antimicrobial Agents and Chemotherapy, 1999, 43(10):2547-2549.
